Baxter International Inc. (BAX) — Analysis Summary
Baxter International Inc. (BAX) has a market cap of $13.41B with year-over-year revenue growth of +5.7%. Net margin stands at -8.5%. The stock trades at a P/E ratio of -12.6.
Key Takeaways
- Revenue changed +5.7% year-over-year
- Net margin of -8.5%
- P/E ratio of -12.6
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, BAX posted revenue growth of +5.7% and trades at a P/E of -12.6.
Baxter International Inc. (BAX)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -1.0x — earnings do not cover interest payments
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
37,500
Headquarters
DEERFIELD, IL
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$0.04
Dividend Yield
0.15%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.